Management and outcomes of intracranial tuberculomas developing during antituberculous therapy: Case report and review

Clinical Pediatrics

Volumn 44, Issue 5, 2005, Pages 443-450

  Jain, Sanjay K ^a   Kwon, Patricia ^a   Moss, William J ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID; ANTIRETROVIRUS AGENT; CARBAMAZEPINE; CIPROFLOXACIN; CORTICOSTEROID; DEXAMETHASONE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; OFLOXACIN; PHENYTOIN; PYRAZINAMIDE; RIFAMPICIN; SPARFLOXACIN; STEROID; STREPTOMYCIN; THYROXINE; TUBERCULOSTATIC AGENT;

BIOPSY; BRAIN VENTRICLE PERITONEUM SHUNT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; INTRACRANIAL TUMOR; LUNG TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; REVIEW; SEIZURE; THORAX RADIOGRAPHY; TREATMENT OUTCOME; TUBERCULOMA; VENTRICULOATRIAL SHUNT;

EID: 20944438153     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/000992280504400510     Document Type: Review

References (10)

1. Sinh G, Pandya SK, Dastur DK. Pathogenesis of unusual intracranial tuberculomas and tuberculous space-occupying lesions. J Neurosurg. 1968; 29:149-159.
2. Awada A, Daif AK, Pirani M, et al. Evolution of brain tuberculomas under standard antituberculous treatment. J Neurol Sci. 1998;156:47-52.
3. Cheng VC, Ho PL, Lee RA, et al. Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients. Eur J Clin Microbiol Infect Dis. 2002;21:803-809.
4. Orlovic D, Smego RAJr. Paradoxical tuberculous reactions in HIV-infected patients. Int J Tuberc Lung Dis. 2001;5:370-375.
5. Hass DW. Mycobacterium tuberculosis. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell: Principles and Practice of Infectious Diseases, 5th ed. Orlando, FL: Churchill Livingstone; 2000:2599.
6. Garcia de Viedma D, Marin M, Ruiz Serrano MJ, et al. Polyclonal and compartmentalized infection by Mycobacterium tuberculosis in patients with both respiratory and extrarespiratory involvement. J Infect Dis. 2003;187:695-699.
7. Ford AL, Foulcher E, Lemckert FA, Sedgwick JD. Microglia induce CD4 T lymphocyte final effector function and death. J Exp Med. 1996;184:1737-1745.
8. Matyszak MK, Perry VH. Bacillus Calmette-Guerin sequestered in the brain parenchyma escapes immune recognition. J Neuroimmunol. 1998; 82:73-80.
9. Constant P, Perez E, Malaga W, et al. Role of the PKS15/1 gene in the biosynthesis of phenolglycolipids in the Mycobacterium tuberculosis complex. Evidence that all strains synthesize glycosylated p-hydroxybenzoic methly esters and that strains devoid of phenolglycolipids harbor a frameshift mutation in the PKS15/1 gene. J Biol Chem. 2002;277:38148-38158.
10. American Thoracic Society/Center for Disease Control and Prevention/Infectious Disease society of America. Treatment of Tuberculosis. Am J Respir Crit Care Med. 2003;167:603-662.